Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Research Report 2023

Publication ID:

PB510234080

Publication Date:

October 24, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Lipidic Cubic Phase (LCP) has become a popular technique for membrane protein crystallization. It has been particularly useful in the field of G-protein Coupled Receptor Protein research, leading to numerous structure solutions. It is the result of mixing aqueous and surfactant components to form a lattice of quasi-lipid phase and aqueous channels that can support membrane protein crystal growth.
The global Lipidic Cubic Phase Crystallization Service market is projected to reach US$ 439.6 million in 2029, increasing from US$ 286 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lipidic Cubic Phase Crystallization Service market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lipidic Cubic Phase Crystallization Service market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH
Segment by Type
Monoolein
Monopalmitolein
Others
Segment by Application
Pharmaceutical Companies
Academic Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lipidic Cubic Phase Crystallization Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoolein
1.2.3 Monopalmitolein
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Companies
1.3.3 Academic Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Perspective (2018-2029)
2.2 Lipidic Cubic Phase Crystallization Service Growth Trends by Region
2.2.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Lipidic Cubic Phase Crystallization Service Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Lipidic Cubic Phase Crystallization Service Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Lipidic Cubic Phase Crystallization Service 麻豆原创 Dynamics
2.3.1 Lipidic Cubic Phase Crystallization Service Industry Trends
2.3.2 Lipidic Cubic Phase Crystallization Service 麻豆原创 Drivers
2.3.3 Lipidic Cubic Phase Crystallization Service 麻豆原创 Challenges
2.3.4 Lipidic Cubic Phase Crystallization Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipidic Cubic Phase Crystallization Service Players by Revenue
3.1.1 Global Top Lipidic Cubic Phase Crystallization Service Players by Revenue (2018-2023)
3.1.2 Global Lipidic Cubic Phase Crystallization Service Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lipidic Cubic Phase Crystallization Service Revenue
3.4 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Concentration Ratio
3.4.1 Global Lipidic Cubic Phase Crystallization Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipidic Cubic Phase Crystallization Service Revenue in 2022
3.5 Lipidic Cubic Phase Crystallization Service Key Players Head office and Area Served
3.6 Key Players Lipidic Cubic Phase Crystallization Service Product Solution and Service
3.7 Date of Enter into Lipidic Cubic Phase Crystallization Service 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Lipidic Cubic Phase Crystallization Service Breakdown Data by Type
4.1 Global Lipidic Cubic Phase Crystallization Service Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Lipidic Cubic Phase Crystallization Service Forecasted 麻豆原创 Size by Type (2024-2029)
5 Lipidic Cubic Phase Crystallization Service Breakdown Data by Application
5.1 Global Lipidic Cubic Phase Crystallization Service Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Lipidic Cubic Phase Crystallization Service Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size (2018-2029)
6.2 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2018-2023)
6.4 North America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Size (2018-2029)
7.2 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2018-2023)
7.4 Europe Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size (2018-2029)
9.2 Latin America Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Lipidic Cubic Phase Crystallization Service 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cube Biotech
11.1.1 Cube Biotech Company Detail
11.1.2 Cube Biotech Business Overview
11.1.3 Cube Biotech Lipidic Cubic Phase Crystallization Service Introduction
11.1.4 Cube Biotech Revenue in Lipidic Cubic Phase Crystallization Service Business (2018-2023)
11.1.5 Cube Biotech Recent Development
11.2 Creative Biostructure
11.2.1 Creative Biostructure Company Detail
11.2.2 Creative Biostructure Business Overview
11.2.3 Creative Biostructure Lipidic Cubic Phase Crystallization Service Introduction
11.2.4 Creative Biostructure Revenue in Lipidic Cubic Phase Crystallization Service Business (2018-2023)
11.2.5 Creative Biostructure Recent Development
11.3 Formulatrix
11.3.1 Formulatrix Company Detail
11.3.2 Formulatrix Business Overview
11.3.3 Formulatrix Lipidic Cubic Phase Crystallization Service Introduction
11.3.4 Formulatrix Revenue in Lipidic Cubic Phase Crystallization Service Business (2018-2023)
11.3.5 Formulatrix Recent Development
11.4 Anatrace
11.4.1 Anatrace Company Detail
11.4.2 Anatrace Business Overview
11.4.3 Anatrace Lipidic Cubic Phase Crystallization Service Introduction
11.4.4 Anatrace Revenue in Lipidic Cubic Phase Crystallization Service Business (2018-2023)
11.4.5 Anatrace Recent Development
11.5 Jena Bioscience GmbH
11.5.1 Jena Bioscience GmbH Company Detail
11.5.2 Jena Bioscience GmbH Business Overview
11.5.3 Jena Bioscience GmbH Lipidic Cubic Phase Crystallization Service Introduction
11.5.4 Jena Bioscience GmbH Revenue in Lipidic Cubic Phase Crystallization Service Business (2018-2023)
11.5.5 Jena Bioscience GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Cube Biotech
Creative Biostructure
Formulatrix
Anatrace
Jena Bioscience GmbH

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.